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administration and testing
U Barahmand, E Tavakolian1, A Khazaee1, K Mohammadi2
Department of Psychology, City University of New York, USA, 1Department of Psychology, University of Mohaghegh
Ardabili, 2Department of Psychology, Shahrekord University, Shahrekord, Iran

Abstract

Context: Methadone maintenance is a standard treatment for opiate‑dependent individuals. However, deficits in cognitive
functioning have been associated with this treatment.
Aim: This study aimed to determine the dose and treatment duration‑related effects of methadone on executive functions.
Setting and Design: Pure male opioid users with no considerable history of other drug abuse, undergoing methadone
maintenance treatment (MMT) were recruited from a major government‑run de‑addiction center.
Methods: Hot executive functions including decision‑making and emotion recognition were assessed using the Iowa
gambling task and Ekman faces test, whereas cold executive functions including working memory (WM), cognitive flexibility,
and response inhibition were assessed using n‑back, Wisconsin card sorting test, and the GO/NOGO task, respectively.
Statistical Analyses Used: Descriptive statistics, Pearson’s correlation coefficients, and multiple regression analysis
were used to test the hypotheses of the study.
Results: Methadone dose and length of MMT were found to be associated with greater impairment in executive
functions. Impairment in cognitive performance was also found to be inversely related to time since dosing. Regression
analyses revealed that methadone dosage and time since dosing accounted for a significant proportion of the variance
in cognitive flexibility, while the total amount of methadone administered was able to predict deficits in WM, methadone
treatment duration predicted psychomotor speed, and time since dosing predicted decision‑making ability.
Conclusions: To keep cognitive impairment at a minimum, methadone dose and treatment duration will have to be
customized considering the history of opiate abuse so that impairment attributable to long‑term opiate use may be
differentiated from acute methadone dosing.
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Introduction
Opiate dependence is a serious health hazard worldwide, and
in most countries, methadone substitution treatment is the
standard evidence‑based treatment for opiate‑dependent
individuals. Methadone maintenance treatment (MMT)
is a comprehensive treatment program that involves the
prescription of methadone as an alternative to the opioid
on which the individual was dependent. Research has
demonstrated that once the individual is stabilized at the
right dose, long‑term methadone prescription alleviates
withdrawal symptoms, blocks euphoric effects, and reduces
craving associated with opioids.[1] Methadone has also been
reported to improve physical and mental health, social
functioning, and quality of life.[2] In terms of benefits for
society, MMT has the potential to reduce illicit drug use,
criminal activity, and incidence of HIV infection.[3‑7]
Despite the potential benefits of MMT, some studies have
indicated that chronic opiate use, whether naturally occurring
or synthetic, is associated with several neuropsychological
impairments both during active use and after a period of
abstinence.[8] The deficits in neuropsychological functioning
reported for individuals undergoing MMT are prominent in
what are called executive functions.[9] Executive functions
are defined as a set of higher‑order abilities including
initiation, inhibition, cognitive flexibility, shifting, switching,
planning, speed of processing, and decision‑making
involved in the employment, monitoring, and regulation
of goal‑directed behaviors.[10] Recent evidence suggests
that these functions can be classified into two broad
domains: (i) Cold executive functions that demand greater
use of rationality and logic, such as working memory (WM),
cognitive flexibility, response inhibition, and planning
and (ii) hot executive functions that involve emotion, such
as decision‑making and emotion perception.[11]
Methadone‑associated cognitive impairment in both hot
and cold executive functions such as attention, WM,
processing speed, decision‑making, and cognitive flexibility
has been documented.[12‑22]

users have also produced mixed results. Curran found that
while a single dose of methadone may induce episodic
memory impairment in patients who have a history of
heroin use, methadone administered in divided doses does
not.[24] Similarly, Lyvers and Yakimoff found that patients
in early methadone withdrawal made selectively more
perseverative responses and errors than did recently dosed
patients.[25] Higher methadone doses were associated with
worse cognitive function during peak state in two studies,
while other studies have shown improved performance.[26,27]
For instance, Bracken compared short‑ and long‑term
methadone‑maintained individuals.[12] Their study showed
that methadone‑maintained individuals performed poorly
on tasks of psychomotor speed and selective attention/
impulsivity, but that performance improves with longer‑term
treatment, suggesting that with longer methadone
maintenance, deficits in cognitive task performance
may begin to normalize. Some researchers reported no
association between methadone dose level and cognitive
performance.[28,29] More recently, Rass studied the effects
of time relative to dosing and maintenance dose level
on cognitive performance in methadone‑maintained
individuals. This study revealed that the effects of
maintenance dose were mixed. Higher dose resulted in
worse performance on attention and WM, but improved
performance on executive function.[16]
Given that the main aim of MMT for opioid‑dependent
individuals is to increase treatment retention and opioid
abstinence, improve psychosocial functioning, and facilitate
treatment of other co‑morbid medical and psychiatric
conditions, a thorough analysis of any dose‑dependent
impairment in the cognitive functioning of individuals
undergoing MMT is essential so as to facilitate comprehensive
rehabilitation of opioid‑dependent individuals.[30] However,
with inconsistent research findings, the question of whether
MMT, and in particular, the dosage and duration of methadone
are associated with better or worse cognitive functioning is
still unresolved and calls for further investigation.

However, a number of studies have failed to replicate these
findings, rendering them inconsistent. Rapeli suggested
that cognitive deficits during early abstinence from opioid
dependence are partly transient and related to neural
dysregulation in the prefrontal cortex induced by withdrawal.[22]
Gruber claimed that MMT results in a significant improvement
in the cognitive performance of opiate‑dependent subjects.[23]
Soyka assessed the cognitive functioning of individuals during
MMT and reported significantly improved concentration and
executive functions after 8–10 weeks of stable methadone
substitution treatment.[17]

Some researchers have speculated that the mixed effects of
methadone dosage and duration on executive functions may
be related to the plasma levels of methadone, which vary as
a function of the time elapsed since the methadone dose. For
example, performance in WM and cognitive flexibility tests
were worse during peak levels of methadone (a couple of
hours after methadone administration) whereas Lyvers and
Yakimoff reported better executive cognitive performance
among recently dosed individuals (90 min after methadone
dose) than those in early withdrawal (24 h after methadone
dose).[16,17,25,31] These findings imply that methadone plasma
levels must be considered while studying executive function
deficits and improvements in patients undergoing MMT.

Studies of the effects of methadone dosing on the
neuropsychological functioning of current methadone

The intent of the present study was to explore the
association of methadone dose, consumption, and treatment
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duration with cognitive functioning in opiate‑dependent
individuals. As most previous studies reported findings based
on data from poly substance users, in this study, individuals
without a considerable history of other substance abuse were
recruited. Furthermore, we studied the effect of total amount
of methadone consumed by each participant (dose per
day × duration of treatment × number of administrations
per month), as we suspected, it might affect the cognitive
functions of individuals undergoing MMT. Based on
inconsistent findings from prior studies, we hypothesized
that performance on the measures of executive functions
would correlate with time since dosing, albeit with no
certainty regarding the direction of the association.

Methods
Ethics statement
This research protocol was approved by the Ethics
Committee of the University of Mohaghegh Ardabili,
Iran, and informed consent was obtained from the study
participants prior to administration of the questionnaires.
Participants
Thirty‑four right‑handed opioid‑dependent men were
recruited from two outpatient MMT clinics in Shahrekord,
Iran. They were interviewed by two experienced clinicians,
and individuals were included if they were pure opioid users
in accordance with Diagnostic and Statistical Manual of
Mental Disorders (DSM)‑5 criteria, on a stable dose of
methadone in the last 2 months, able to read, and not
used any substance other than methadone in the last
2 weeks. Individuals were excluded if they had hepatitis
C or HIV virus infection, a history of head trauma, a
neurodegenerative disease, or a psychiatric disorder based
on DSM‑5 criteria. All participants received detailed
information about the study protocol, gave written informed
consent, and were paid as reimbursement of travel costs
incurred for participation in this study.
Forty‑one males undergoing MMT volunteered to
participate in the study. Seven participants were excluded as
they failed to meet the inclusion criteria: One had a history
of severe psychosomatic disorder including temporary
blindness and paralysis, one had a seizure in the last month,
one had Parkinson’s disease, one had active hepatitis C virus,
one reported having hallucinations, one had administered
methadone during testing, and one did not complete all
tests. Participants had no difficulty in completing the tests.
Data were collected by the second author over a period of
60 days. The final sample comprised 34 opiate‑dependent
males undergoing MMT. Each participant completed the
tests in one session with a 3 min break between tests.
It took approximately two and a half to three hours for
each individual to complete all the tests. The order of test
administration was counterbalanced.

Neurocognitive measures
Decision‑making

Decision‑making was assessed with the Iowa gambling
task (IGT).[32] The aim of this task is to simulate real life
decision‑making using uncertainty, rewards, and penalties.
In the game, players are given four decks of cards and an
endowment of fake money. Players are instructed to select
cards one at a time and try to lose the least amount of money
and win the most. Turning a card results in a reward or a
penalty, large in decks A and B and small (half as much)
in decks C and D. Playing from decks A and B leads to an
overall loss, whereas playing C and D leads to an overall
gain. Players do not know how many cards will be in the
decks. After encountering a few losses, normal participants
begin to avoid the decks with large losses. The main
dependent variable on this task was the net score on each
block of the task. Net scores were calculated by subtracting
the number of disadvantageous choices (decks A and B)
from the number of advantageous choices (decks C and D)
for each block. The test took 20–25 min to administer.
Emotion perception

The Ekman faces test is a computer task assessing
recognition of facial emotional expressions. A series of 36
stimuli featuring faces displaying 6 basic emotions such as
anger, disgust, fear, happiness, sadness, and surprise (six
emotions, six faces each) were presented. The number of
correct identifications for each of the six emotions and
the total correct identifications were the main dependent
variables from this task.[33] There was no time limit for the
test, but all individuals completed the test within 40 min.
Cognitive flexibility

The Wisconsin card sorting test (WCST) was used to assess
cognitive flexibility, presenting the task graphically on a
computer screen. This task is thought to measure the ability
to switch one’s attentional set as task demands change. The
WCST entails matching stimulus cards with one of the four
category cards, in which the stimuli are multidimensional
according to color (C), shape (S), and number (N), each
dimension defining a sorting rule. By trial and error, the
participant has to settle a preordained sorting rule given
just the feedback (“right” or “wrong”) on the screen after
each sort. Two types of errors are possible, perseverative
errors, in which the participants make a response in which
they persist with a wrong sorting rule and nonperseverative
errors.[34] In this study, perseverative errors were used as
dependent variables. The test took between 30 and 40 min
to administer.
Working memory

A blocked WM task based on the classical “n‑back” WM
paradigm was used.[35] Subjects viewed a sequence of
single digits that were presented in random order at a rate
of 1/s. They were instructed to determine if the current
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digit was the same as the one displayed two (2‑back
target) steps before in the sequence. There were 120 trials.
5457872393161 is an example of the sequence of digits for
2‑back trial highlighting the four 2‑back targets. Button
press events were used to record WM accuracy (the relative
difference between hits and false alarms) and reaction
times.[35‑37] The test took 25–30 min to administer.
Response inhibition

The GO/NOGO task was used to determine response
inhibition in participants. The traditional, simple format
of this task allows for examination of response inhibition
under conditions in which other cognitive/behavioral
processes are minimized. The traditional GO/NOGO
task design involves only two stimuli: A Go stimulus and
a No‑go stimulus. Participants are instructed to respond
rapidly, generally with a button press, to the presentation
of GO stimuli only, and response inhibition is measured by
the ability to appropriately withhold responding to NOGO
stimuli. Typically, the task is weighted toward GO stimuli,
to build up a prepotent tendency to respond, thereby
increasing the inhibitory effort necessary to successfully
withhold responding to NOGO stimuli.[38,39] In this study,
a blue square was used as a “GO” clue and a red square as
the “NOGO” clue. Reaction time on GO trials, commission
errors, and inability to refrain from pressing the button
when seeing NOGO clue, which show impulsivity, were
used as dependent variables. Administration of the test
took 20–25 min.

Results
Table 1 represents demographic information and descriptive
statistics. Participants were 34 pure opioid‑dependent
individuals aged between 22 and 45 (m = 33.6,
standard deviation [SD] =4.5) with an average of
9.3 years (SD = 2.9) of education. Mean years of opioid
abuse was 6.94 (SD = 5.23). Of the 34 participants, 33
participants (97%) smoked. Mean duration of MMT was
23.18 (SD = 13.80) months, and the average dosage of
methadone administration was 12.62 mg (SD = 6.91).
The total amount of methadone administered was
1316.05 mg (SD = 1096.65).
Table 2 presents the scores of the participants on the various
tests of executive functions. Correlations among methadone
dose, MMT duration, total amount of methadone consumed,
and the time (in hours) elapsed between last methadone
administration and test procedure with participants’ scores
on cold executive function tasks including WCST, 2‑back,
and GO/NOGO tasks are presented in Table 3.
As Table 3 shows the number of perseverative errors which
shows cognitive flexibility deficits correlate significantly
with methadone dosage, the total amount of methadone
606

Table 1: The demographic and methadone use
characteristics of the participants
Minimum Maximum Mean
Age (years)
Education (years)
Opioid use (years)
Methadone dose (mg)
MMT duration (months)
Total amount of methadone
administered (mg)
Last administration of
methadone (hours)

22.00
3.00
00
10.00
3.00
105.00

45.00
16.00
18.00
175.00
72.00
5250.00

0.50

24.00

SD

33.61
4.57
9.29
2.89
6.94
5.22
60.10
34.55
22.17
13.80
1316.05 1096.65
8.16

6.12

MMT=Methadone maintenance treatment; SD=Standard deviation

Table 2: Mean scores of the participants on the
various measures
Tests
Wisconsin
Perseveration errors
2‑back
GO/NOGO
Reaction time
Commission errors
IGT cards
A
B
C
D
Net score
Emotion perception
Sad
Surprise
Happy
Fear
Angry
Disgust
Total emotion perception

Minimum

Maximum

Mean

SD

1.00
16.00

20.00
34.00

7.29
26.50

4.30
4.21

297.00
00

543.00
21.00

373.88
2.61

50.88
3.58

15.00
20.00
15.00
13.00
−32.00

34.00
38.00
33.00
37.00
21.00

25.32
26.76
23.26
24.67
−2.26

4.61
4.72
4.51
5.10
12.28

1.00
1.00
4.00
00
00
1.00
14.00

5.00
6.00
6.00
6.00
5.00
6.00
30.00

3.82
4.76
5.32
2.85
2.32
3.26
22.23

1.05
1.20
0.72
1.63
1.19
1.42
3.5

SD=Standard deviation; IGT=Iowa gambling task; GO/NOGO=???

Table 3: Correlation coefficients showing the association
of cold executive function scores with methadone dose,
treatment duration, total methadone consumed, and
time elapsed between last methadone dose and testing
Methadone MMT
Total
Time between
dosage duration amount of last methadone
methadone
dose and
consumed
testing
WCST
2‑back
GO/NOGO
reaction time
GO/NOGO
commission
errors

0.534**
−0.370*
0.244

0.049
−0.398*
0.419*

0.501**
−0.569**
0.434*

0.384*
−0.052
0.041

−0.009

−0.218

−0.072

−0.050

MMT=Methadone maintenance treatment; WCST=Wisconsin card sorting
test
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that had been consumed, and the time between last
methadone administration and test performance which is
directly related to methadone concentration level in plasma.
However, deficits in cognitive flexibility failed to correlate
with MMT duration. The number of correct answers in
2‑back task which represents WM capacity was significantly
and negatively associated with both methadone dosage
and MMT duration and the total amount of methadone
consumed. There is no correlation between WM capacity
and the time between last methadone dosing and test
performance. Participants’ reaction time in GO/NOGO
positively correlated with MMT duration and total amount
of methadone used. However, there was no correlation
between reaction time with methadone dosage and last time
of methadone administration. The number of commission
errors in GO/NOGO task did not correlate with methadone
usage.
Table 4 represents correlation coefficients among hot
executive functions and methadone dosage, MMT duration,
total methadone consumption, and time since dosing.
As shown in Table 4, IGT net score did not correlate
significantly with methadone dosage, MMT duration,
or total amount of methadone consumed. However, a
point biserial correlation between methadone‑maintained
patients who made good and bad decisions and time between
last methadone dosing and testing were highly significant.
This indicates that the greater the time between dosing and
testing, the better the decisions made. In other words, it can
be assumed that as methadone concentration level in plasma
Table 4: Correlation coefficients showing the association
of hot executive function scores with methadone dose,
treatment duration, total methadone consumed, and time
elapsed between last methadone dose and testing
Methadone MMT
Total
Time
dosage duration amount of between last
methadone methadone
consumed dose and
testing
IGT net score
Emotion perception:
Sadness
Emotion perception:
Surprise
Emotion perception:
Happiness
Emotion perception:
Fear
Emotion perception:
Anger
Emotion perception:
Disgust
Emotion perception:
Total score

−0.049
−0.299

−0.212
0.452**

−0.098
0.090

0.384*
0.059

0.025

0.137

0.121

0.074

−0.192

0.384*

0.169

−0.045

−0.122

−0.286

−0.344*

−0.078

−0.416*

0.324

−0.155

−0.048

−0.291

0.263

−0.058

0.294

−0.433*

0.360*

−0.118

0.104

MMT=Methadone maintenance treatment

decreases, participants chose more advantageous cards and
made more safe decisions. Methadone dosage correlated
negatively with an accuracy of anger perception and total
emotion perception scores. MMT duration positively
correlated with interpretations of sadness and happiness
and total scores of emotion perception. Total methadone
consumption correlated significantly with the accuracy of
fear perception. Time since dosing failed to correlate with
emotion perception.
Finally, regression analyses were run to predict each of
the indices of executive function using methadone dose,
total amount of methadone consumed, duration of MMT,
and time since dosing as predictors. Results demonstrated
that methadone dose (β = 0.534, t = 3.58, P < 0.01) and
time between dosing and testing (β = 0.319, t = 2.307,
P < 0.05) accounted for 28.6% and 10% of the variance
in cognitive flexibility deficits indicated by perseveration
errors, respectively; total amount of methadone consumed
accounted for 32.3% of the variance in WM deficits;
duration of MMT (β = 0.569, t = −3.911, P < 0.01)
explained 18.8% of the variance in psychomotor speed; time
since dosing and testing (β = 0.384, t = 2.353, P < 0.05)
accounted for 14.8% of the variance in decision‑making
ability; and methadone dose (β = −0.433, t = −2.718,
P < 0.05) accounted for 18.8% of the variance in emotion
perception.

Discussion
The present study used a single sample design to investigate
the association of methadone dose, duration of MMT, total
amount of methadone consumed, and time elapsed since last
dose with hot and cold executive functions in methadone
maintenance patients.
Analysis of the effects of methadone dose revealed that
among the cold executive functions, deficits in cognitive
flexibility correlated positively with methadone dose
indicating that individuals who were receiving a higher
dose of the drug revealed greater deficits. WM scores
correlated negatively with methadone dose implying that
higher doses of the drug are associated with greater deficits
in WM. Indices of response inhibition (reaction time and
commission errors) did not correlate significantly with
methadone dose suggesting that neither psychomotor
speed nor impulsivity is affected by the strength of the
dosage of the drug. As regards hot executive functions,
methadone dose was associated with deficits in emotion
perception, especially the perception of anger, but not with
decision‑making.
Such mixed effects of methadone dose on cognitive
performance are consistent with the literature. Studies
exploring the association of methadone dose and cognitive
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performance have produced controversial results.
For example, Kelly found higher doses of methadone
therapeutically more effective whereas Loeber found
higher doses of methadone associated with worse cognitive
performance and Darke found no association between
methadone dose and cognitive performance.[27,28,40] Impaired
performance of methadone‑maintained patients in WM
is consistent with the results of previous studies.[14,41]
However, the fact that methadone dose did not correlate
with psychomotor speed and decision‑making is inconsistent
with these studies. Evidence for deficits in attention, WM,
memory, and executive function in chronic opioid abusers
have been reported.[22] It is difficult to differentiate whether
the cognitive dysfunctions seen in the present sample are
a consequence of acute methadone dosing or reflective of
the effect of previous opioid use.
Duration of MMT correlated significantly with deficits in
WM and psychomotor speed (longer reaction time), but not
with deficits in cognitive flexibility. Exposure to MMT was
also associated with better emotion perception, especially
with the perception of sadness and happiness. That is, the
longer a person is exposed to MMT, the greater the deficits
in WM and the slower his cognitive performance, but the
better his ability to perceive emotions.
Furthermore, total amount of methadone consumed by the
patient undergoing MMT was significantly associated with
deficits in cognitive flexibility, WM, psychomotor speed,
and deficits in the perception of fear.
Multiple regression analyses imply that while the strength of
methadone dose may affect cognitive flexibility, as time since
dosing increases, decision‑making improves. Furthermore,
the total amount of methadone consumed impacts WM
adversely, and duration of MMT tends to slow down mental
processing.
Taken together, these findings imply that while MMT may
be beneficial in reducing opiate dependence, suppressing
withdrawal symptoms, and blocking euphoric effects of
opioids, methadone dose level used should be maintained
at an optimal level so as to prevent the occurrence of
deficits in cognitive flexibility, and WM and the duration
of MMT should be tailored so that cognitive functioning
does not worsen. When exposure to MMT gets longer,
WM gets even more deficient, and cognitive performance
is slowed although emotion perception may improve.
While the length of exposure to MMT may have to be
controlled, it is the total amount of methadone consumed
by the individual during therapy that worsens executive
functions. Findings indicate that methadone dose affects
cognitive performance. Rapeli suggested that cognitive
deficit during early opioid abstinence may be associated
with neural dysregulations in the prefrontal cortex induced
by withdrawal and that rapid recovery of cognitive function
608

during opioid abstinence seems possible.[22] In fact, some
studies have shown that cognitive performance improves
with stabilization of methadone dose.[12,42] However, in
the present study, longer MMT was associated with worse
cognitive performance. This inconsistency of the findings
from this study with previous studies may be attributable
to differences in sample characteristics. In the current
study, only pure opiate users were recruited whereas the
previous studies reported findings for poly substance users.
Curran suggested that the acute effects of methadone on
the cognitive functioning of patients in MMT with a long
history of opiate abuse can be avoided by administering
divided doses of methadone.[24] Longitudinal studies are
needed to confirm these suggestions.
Time since dosing correlated positively only with deficits
in cognitive flexibility and decision‑making, but not
with deficits in WM or response inhibition. That is, as
time since dosing increased, individuals showed worse
performance when they have to simultaneously attend
to multiple sources of information and make decisions.
In other words, it can be inferred that methadone does
affect cognitive flexibility and decision‑making positively
so that cognitive performance during peak sessions may
be facilitated by methadone. Cognitive performance
differences as a function of session (peak vs. trough)
have been reported in previous research. Baewert
found that methadone‑maintained patients made more
perseverative errors on the WCST when time since dosing
was 24 h (trough session) than when it was 90 min (peak
session). [43] Findings of the current study appear to
confirm these previous findings as the performance of the
individuals in this study tended to worsen as time since
dosing increased. Performance on the IGT showed that
subjects tended to make more advantageous decisions
as time since dosing increased. These findings confirm
those of previous studies that cognitive performance in
methadone patients may be a function of time elapsed
since last dosing.[16,25,43] Using a within‑subjects design and
comparing the performance of MMT patients in peak and
trough sessions, Rass reported worse performance during
the peak session.[16] The findings of the present study that
MMT patients performance changed as a function of time
relative to dosing is consistent with these previous results.
That is, it appears that decision‑making is a function of the
concentration of methadone in blood plasma.
In sum, it appears that regardless of dosage, methadone
administration is associated with impairment in the
decision‑making ability of individuals, but as time since
dosing increases, decision‑making appears to improve.
The strength of methadone dose is directly associated
with deficits in WM and cognitive flexibility, whereas it is
not associated with psychomotor speed or impulsiveness.
However, as treatment continues, deficits in WM and
psychomotor speed continue to worsen whereas treatment

Nigerian Journal of Clinical Practice • Sep-Oct 2016 • Vol 19 • Issue 5

[Downloaded free from http://www.njcponline.com on Tuesday, July 24, 2018, IP: 128.228.136.210]
Barahmand, et al.: Executive functions in methadone maintenance patients

duration does not worsen cognitive flexibility. The total
amount of methadone consumed is directly associated with
deficits in WM, cognitive flexibility, psychomotor speed,
and emotion perception. These results underscore the
importance of manipulating methadone dose and treatment
duration on an individual basis so that while therapy is
effective in eliminating opiate dependence, the likelihood of
cognitive impairments is minimized. Future studies in which
the time relative to methadone dosing is systematically
manipulated across different doses of methadone and for
patients with varying history of opiate dependence will be
able to shed more light on this issue.

2.

3.
4.

5.

6.

7.

The strength of the present study is that pure opiate users
were studied and much longer MMT duration (as long as
6 years). Studies that reported normalization of cognitive
performance had reported findings relevant to a few weeks
and few months of MMT. The present study suggests that
with longer durations of MMT, while psychomotor speed
and WM may normalize, deficits in cognitive flexibility may
continue and be a function of time relative to last dosing.
With respect to methadone maintenance dose level, in
contrast with a recent study, this study indicates that higher
doses of methadone do increase the risk of impairment in
executive functions.[16] This study also implies that to keep
cognitive impairment at a minimum, methadone dose and
treatment duration will have to be customized considering
the history of opiate abuse so that impairment attributable
to long‑term opiate use may be differentiated from acute
methadone dosing. Longitudinal within‑subject studies
are needed to provide detailed information regarding the
effects of methadone dose and amount as well as length of
MMT and their interactions with time relative to dosing
on executive functions.
It should be noted that the implications of the findings
may be tempered by the fact that the possible contribution
of patient characteristics such as level of education and
history of psychopathology was not considered. Further
investigation with larger samples controlling these factors
may provide more useful data.
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11.
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13.

14.
15.

16.

17.

18.

19.

The current study indicates the distinct effects of short‑ and
long‑term methadone administration and underscores the
importance of a customized treatment for opiate users.

20.

Financial support and sponsorship
Nil.

22.

Conflicts of interest
There are no conflicts of interest.

23.

References
1.

Wang Y, Wang H, Li W, Zhu J, Gold MS, Zhang D, et al. Reduced responses
to heroin‑cue‑induced craving in the dorsal striatum: Effects of long‑term

21.

24.

25.

methadone maintenance treatment. Neurosci Lett 2014;581:120‑4.
De Maeyer J, Vanderplasschen W, Camfield L, Vanheule S, Sabbe B, Broekaert
E. A good quality of life under the influence of methadone: A qualitative study
among opiate‑dependent individuals. Int J Nurs Stud 2011;48:1244‑57.
Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT):
A review of historical and clinical issues. Mt Sinai J Med 2000;67:347‑64.
Flynn PM, Porto JV, Rounds‑Bryant JL, Kristiansen PL. Costs and benefits of
methadone treatment in DATOS‑part 2: Gender differences for discharged
and continuing patients. J Maint Addict 2002;2:151‑69.
Gossop M, Trakada K, Stewart D, Witton J. Reductions in criminal
convictions after addiction treatment: 5‑year follow‑up. Drug Alcohol Depend
2005;79:295‑302.
Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with
methadone maintenance therapy use among a cohort of polysubstance using
injection drug users in Vancouver. Drug Alcohol Depend 2005;80:329‑35.
Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid
dependence. Lancet 1999;353:221‑6.
Baldacchino A, Balfour DJ, Passetti F, Humphris G, Matthews K.
Neuropsychological consequences of chronic opioid use: A quantitative
review and meta‑analysis. Neurosci Biobehav Rev 2012;36:2056‑68.
Fernández‑Serrano MJ, Pérez‑García M, Verdejo‑García A. What are the
specific vs. generalized effects of drugs of abuse on neuropsychological
performance? Neurosci Biobehav Rev 2011;35:377‑406.
Verdejo‑García A, Bechara A. Neuropsychology of executive functions.
Psicothema 2010;22:227‑35.
Kerr A, Zelazo PD. Development of “hot” executive function: The children’s
gambling task. Brain Cogn 2004;55:148‑57.
Bracken BK, Trksak GH, Penetar DM, Tartarini WL, Maywalt MA, Dorsey CM,
et al. Response inhibition and psychomotor speed during methadone
maintenance: Impact of treatment duration, dose, and sleep deprivation. Drug
Alcohol Depend 2012;125:132‑9.
Kornreich C, Foisy ML, Philippot P, Dan B, Tecco J, Noël X, et al. Impaired
emotional facial expression recognition in alcoholics, opiate dependence
subjects, methadone maintained subjects and mixed alcohol‑opiate
antecedents subjects compared with normal controls. Psychiatry Res
2003;119:251‑60.
Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance
patients. Drug Alcohol Depend 2002;67:41‑51.
Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, et al. Impaired
decision‑making in opiate‑dependent subjects: Effect of pharmacological
therapies. Drug Alcohol Depend 2006;83:163‑8.
Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML,
et al. Cognitive performance in methadone maintenance patients: Effects of
time relative to dosing and maintenance dose level. Exp Clin Psychopharmacol
2014;22:248‑56.
Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, et al. Cognitive
functioning during methadone and buprenorphine treatment: Results of a
randomized clinical trial. J Clin Psychopharmacol 2008;28:699‑703.
Verdejo A, Toribio I, Orozco C, Puente KL, Pérez‑García M. Neuropsychological
functioning in methadone maintenance patients versus abstinent heroin
abusers. Drug Alcohol Depend 2005;78:283‑8.
Darke S, McDonald S, Kaye S, Torok M. Comparative patterns of cognitive
performance amongst opioid maintenance patients, abstinent opioid users
and non‑opioid users. Drug Alcohol Depend 2012;126:309‑15.
Davis PE, Liddiard H, McMillan TM. Neuropsychological deficits and opiate
abuse. Drug Alcohol Depend 2002;67:105‑8.
Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive
performance. Drug Alcohol Depend 2005;78:225‑30.
Rapeli P, Kivisaari R, Autti T, Kähkönen S, Puuskari V, Jokela O, et al. Cognitive
function during early abstinence from opioid dependence: A comparison
to age, gender, and verbal intelligence matched controls. BMC Psychiatry
2006;6:9.
Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, et al.
Methadone maintenance improves cognitive performance after two months
of treatment. Exp Clin Psychopharmacol 2006;14:157‑64.
Curran HV, Kleckham J, Bearn J, Strang J, Wanigaratne S. Effects of methadone
on cognition, mood and craving in detoxifying opiate addicts: A dose‑response
study. Psychopharmacology (Berl) 2001;154:153‑60.
Lyvers M, Yakimoff M. Neuropsychological correlates of opioid dependence
and withdrawal. Addict Behav 2003;28:605‑11.

Nigerian Journal of Clinical Practice • Sep-Oct 2016 • Vol 19 • Issue 5

609

[Downloaded free from http://www.njcponline.com on Tuesday, July 24, 2018, IP: 128.228.136.210]
Barahmand, et al.: Executive functions in methadone maintenance patients
26. Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H. Methadone
vs. buprenorphine/naloxone during early opioid substitution treatment:
A naturalistic comparison of cognitive performance relative to healthy
controls. Pharmacol Toxicol 2007;7:5.
27. Loeber S, Kniest A, Diehl A, Mann K, Croissant B. Neuropsychological
functioning of opiate‑dependent patients: A nonrandomized comparison
of patients preferring either buprenorphine or methadone maintenance
treatment. Am J Drug Alcohol Abuse 2008;34:584‑93.
28. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among
methadone maintenance patients. Addiction 2000;95:687‑95.
29. Soyka M, Hock B, Kagerer S, Lehnert R, Limmer C, Kuefner H. Less
impairment on one portion of a driving‑relevant psychomotor battery in
buprenorphine‑maintained than in methadone‑maintained patients: Results
of a randomized clinical trial. J Clin Psychopharmacol 2005;25:490‑3.
30. Tetrault JM, Fiellin DA. Current and potential pharmacological treatment
options for maintenance therapy in opioid‑dependent individuals. Drugs
2012;72:217‑28.
31. Rapeli P, Fabritius C, Kalska H, Alho H. Cognitive functioning in
opioid‑dependent patients treated with buprenorphine, methadone, and
other psychoactive medications: Stability and correlates. Pharmacol Toxicol
2011;11:13.
32. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future
consequences following damage to human prefrontal cortex. Cognition
1994;50:7‑15.
33. Young A, Perrett D, Calder A, Sprengelmeyer R, Ekman P. Facial Expressions
of Emotion: Stimuli and Tests (FEEST). Bury St. Edmunds: Thames Valley Test
Company; 2002.
34. Heaton R, Chelune G, Talley J, Kay G, Curtiss G. Wisconsin Card Sorting Test

610

35.
36.
37.

38.

39.

40.

41.

42.

43.

Manual: Revised and Expanded. Odessa, Florida: Psychological Assessment
Resources Inc.; 1993.
Gevins AS, Morgan NH, Bressler SL, Cutillo BA, White RM, Illes J, et al. Human
neuroelectric patterns predict performance accuracy. Science 1987;235:580‑5.
Jaeggi SM, Buschkuehl M, Perrig WJ, Meier B. The concurrent validity of the
N‑back task as a working memory measure. Memory 2010;18:394‑412.
Tomasi D, Volkow ND, Wang GJ, Wang R, Telang F, Caparelli EC, et al.
Methylphenidate enhances brain activation and deactivation responses to
visual attention and working memory tasks in healthy controls. Neuroimage
2011;54:3101‑10.
Bokura H, Yamaguchi S, Kobayashi S. Electrophysiological correlates
for response inhibition in a Go/NoGo task. Clin Neurophysiol
2001;112:2224‑32.
Simmonds DJ, Pekar JJ, Mostofsky SH. Meta‑analysis of Go/No‑go tasks
demonstrating that fMRI activation associated with response inhibition is
task‑dependent. Neuropsychologia 2008;46:224‑32.
Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP. Predictors of
methadone treatment retention from a multi‑site study: A survival analysis.
Drug Alcohol Depend 2011;117:170‑5.
Brand M, Roth‑Bauer M, Driessen M, Markowitsch HJ. Executive functions
and risky decision‑making in patients with opiate dependence. Drug Alcohol
Depend 2008;97:64‑72.
Soyka M, Zingg C, Koller G, Hennig‑Fast K. Cognitive function in short‑ and
long‑term substitution treatment: Are there differences? World J Biol
Psychiatry 2010;11 (2 Pt 2):400‑8.
Baewert A, Gombas W, Schindler SD, Peternell‑Moelzer A, Eder H, Jagsch R,
et al. Influence of peak and trough levels of opioid maintenance therapy on
driving aptitude. Eur Addict Res 2007;13:127‑35.

Nigerian Journal of Clinical Practice • Sep-Oct 2016 • Vol 19 • Issue 5

